An appeals court has revived a challenge to President Biden's Medicare drug price reduction program
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...
FTC Sues CVS Health, Cigna And United Health Group For Inflating Insulin Prices
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...
Fatal drug overdoses down in the U.S. — but not in Utah and the West
The predictive data for Utah shows a 8.08% increase in overdose deaths — 722 deaths for the yearlong period ending in April ...
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
Steinberg: Requiring treatment will only worsen California’s drug problems
Proposition 36 would slash tens of millions of dollars from treatment programs while driving up incarcerations.
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
STAT3h
First Opinion readers on clinical trials in Africa, compounded semaglutide, depressed mice, and more
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...
Challenge to US drug price negotiation program revived by appeals court
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
Four things you need to know about Medicare drug costs and coverage in 2025
With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the ...
9 Major Medicare Changes for 2025 and How They'll Impact Your Coverage
Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes ...
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
Health Affairs8d
What Medicare Negotiation Tells Us About Drug Pricing In The U.S.
Results from Medicare’s first year of negotiation with other price benchmarks shed light on the competitive dynamics and ...